Immune treatments have moved from broad suppression to blocking single signals. The general trade-off doesn't change: the more you turn down, the more you risk infection. This page is general background, and a prescribing doctor is the person to ask about any specific drug.
How to read the names
| Ending | What it is | Example |
|---|---|---|
| -mab | A monoclonal antibody | Infliximab, rituximab |
| -cept | A receptor fused to an antibody stem | Etanercept |
| -tinib, -citinib | A small molecule blocking an enzyme inside the cell | Tofacitinib, upadacitinib |
| -limus | Blocks T cell signalling | Tacrolimus, sirolimus |
Turning it down
| Class | How it works | Used for | Main risks |
|---|---|---|---|
| NSAIDs | Block prostaglandin production | Pain, inflammation, fever | Stomach, kidneys, heart |
| Antihistamines | Block the histamine receptor | Hay fever, hives | Drowsiness with older types |
| Corticosteroids (prednisone, dexamethasone) | Turn down many inflammatory genes at once | Almost anything, fast | Infection, bones, sugar, mood, weight |
| Methotrexate | Slows fast-dividing cells, and more | Rheumatoid arthritis, psoriasis, Crohn's | Liver, blood counts, not in pregnancy |
| Azathioprine, mycophenolate | Stop lymphocytes dividing | Transplants, lupus, Crohn's | Infections, blood counts, skin cancer |
| Tacrolimus, ciclosporin | Stop T cells making IL-2 | Transplants; tacrolimus ointment for eczema | Kidneys, infections |
| Anti-TNF (infliximab, adalimumab, etanercept) | Block TNF | Rheumatoid arthritis, psoriasis; infliximab and adalimumab also for Crohn's | TB reactivation, serious infection |
| Anti-IL-6R (tocilizumab) | Block IL-6 signalling | Rheumatoid arthritis, CAR-T toxicity | Infections, and hides CRP rise |
| Anti-IL-17, anti-IL-23 (secukinumab, risankizumab) | Block the Th17 axis | Psoriasis; anti-IL-23 also for Crohn's | Thrush; anti-IL-17 can worsen Crohn's |
| Anti-IL-4/13 (dupilumab) | Block type 2 signals | Eczema, asthma | Eye irritation |
| Anti-CD20 (rituximab, ocrelizumab) | Remove B cells | Rheumatoid arthritis, MS, lymphoma | Infections, weak vaccine response |
| Anti-integrin (vedolizumab, natalizumab) | Stop T cells getting into the gut or brain | Crohn's, colitis, MS | Natalizumab: a rare brain infection, PML |
| JAK inhibitors (tofacitinib, upadacitinib) | Block signals from many cytokines | Rheumatoid arthritis, colitis, eczema | Infections (shingles especially), clots, heart events, some cancers |
| IV immunoglobulin | Pooled antibody from donors | Antibody deficiency, some autoimmune disease | Headache, rarely clots |
Turning it up
| Treatment | How it works | Used for |
|---|---|---|
| Vaccines | Teach memory | Prevention |
| Checkpoint inhibitors | Release T cell brakes | Cancer |
| CAR-T cells | Engineer a patient's own T cells | Blood cancers, and early trials in lupus |
| Interferons | Add the antiviral signal | Once hepatitis B and C; interferon beta in MS, which reduces, not increases, inflammation |
| G-CSF | Tells marrow to make neutrophils | After chemotherapy |
| Immunoglobulin replacement | Gives antibodies directly | Antibody deficiency |
Low-dose naltrexone
Naltrexone blocks opioid receptors, normally at about 50 mg a day. At very low doses, about 1.5 to 4.5 mg, it's used off-label for conditions including fibromyalgia, ME/CFS, long COVID and some inflammatory conditions. There are three ideas for how it might work: a rebound in the body's own endorphins, a calming of microglia, and a restored calcium channel in natural killer cells. None is proven.
Early results looked promising, including small placebo-controlled trials in fibromyalgia and Crohn's disease. The larger placebo-controlled trials since then, among them two in fibromyalgia and one in post-COVID fatigue, haven't shown a benefit. Low-dose naltrexone: the idea goes through the three ideas and the trials.
It's generally well tolerated, with vivid dreams being common. It blocks opioid painkillers, so doctors need to know before any surgery or if you're taking opioids.
General principles
- Check first. Many drugs need TB and hepatitis B screening before starting, because they can wake up a hidden infection.
- Vaccinate first if possible. Particularly for B cell-removing drugs. Live vaccines may become unsafe afterwards.
- Don't stop steroids suddenly after more than a few weeks on them, or after repeated short courses. Your own adrenal glands will have slowed down and need time to recover. While they're suppressed, a bad illness or surgery can cause an adrenal crisis, so ask about sick-day doses and carry a steroid card.
- A fever matters more on these drugs, and the usual signs of infection can be hidden.
Medicine has gone from suppressing everything to blocking single signals, but every block has a price, and it's usually a specific kind of infection.